Results 21 to 30 of about 3,894,585 (291)

Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9 years: findings from a real-world retrospective study

open access: yesBMC Endocrine Disorders, 2022
Background GnRHa treatment was established for improving final adult height (FAH) in children presenting with Idiopathic central precocious puberty (ICPP) up to age 8, while several controversies remained for older age groups.
Ming-ming Ni   +6 more
doaj   +1 more source

Developmental fitness curves: assessing sprint acceleration relative to age and maturity status in elite junior tennis players

open access: yesAnnals of Human Biology, 2020
Background The influence of maturity-status on athletic performance is reasonably well-documented. Methodological and practical issues of assessment and lack of longitudinal data have impacted the success of various models.
Gillian K. Myburgh   +3 more
doaj   +1 more source

Prediction of Adult Height in Turner Syndrome [PDF]

open access: yesClinical Pediatric Endocrinology, 1993
Predictions of adult height in girls with Turner Syndrome using established methods, projected height (PROJ), predicted height (PRED), and index of potential height (IPH), were compared to a novel method (KIGS):
Price, David A   +3 more
openaire   +2 more sources

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls

open access: yesFrontiers in Endocrinology, 2022
PurposeTo investigate the effectiveness and safety of gonadotropin-releasing hormone analogue (GnRHa) in combination with recombinant human growth hormone (rhGH) in girls with central precocious puberty (CPP).MethodsClinical data of 80 girls diagnosed ...
Yuzhen Shi   +5 more
doaj   +1 more source

Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2014
PurposeGonadotropin-releasing hormone agonist (GnRHa) is known for improving final adult height in patients with central precocious puberty (CPP). This study aimed to investigate the age of menarche and near adult height in girls with CPP who had been ...
Joon-Woo Baek   +5 more
doaj   +1 more source

Predicting adult height in Turner syndrome [PDF]

open access: yesEuropean Journal of Endocrinology, 2005
Like Wasniewska et al. (1) we also have an interest inthe effect of growth hormone (GH) on growth andfinal adult height in Turner syndrome. Predictingfinal adult height in any individual is far from anexact science, but we believe that Wasniewska’s calcu-lations are flawed; first due to the inappropriate use ofheight standard deviation scores (SDS), and ...
Abbott, R.A.   +2 more
openaire   +4 more sources

The relation between adult height and haemorrhagic and ischaemic stroke in the Renfrew/Paisley study [PDF]

open access: yes, 2001
Adult height is a useful marker of fetal growth, growth and nutrition in childhood and childhood infections. Studies reporting inverse associations between height and stroke therefore provide support for the hypothesis that exposures acting in early life
McCarron, PG   +8 more
core   +1 more source

Predicting the timing of the peak of the pubertal growth spurt in elite male youth soccer players: evaluation of methods

open access: yesAnnals of Human Biology, 2020
Background Three commonly used non-invasive protocols are implemented to estimate the timing at which PHV most likely occurs. Accurate estimation of circumpubertal years can aid in managing training load of adolescent athletes.
James Parr   +7 more
doaj   +1 more source

Predicting the adult height of girls with central precocious puberty [PDF]

open access: yesMedical Science Monitor, 2011
There are no absolute criteria for identifying those girls with idiopathic central precocious puberty (CPP) who will benefit from gonadotropin-releasing hormone analog (GnRHa) treatment. Our objective was to predict at initial evaluation the differences between adult height (AH) and target height (TH) and (for untreated girls) the time between puberty ...
Allali, Slimane   +5 more
openaire   +4 more sources

EFFECT OF AROMATASE INHIBITOR THERAPY ON PREDICTED ADULT HEIGHT IN PREPUBERTAL BOYS WITH IDIOPATHIC SHORT STATURE [PDF]

open access: yesAl-Azhar Journal of Pharmaceutical Sciences, 2015
To investigate the effect of blocking estrogen biosynthesis with anastrozole, a potent aromatase inhibitor (AI) on growth and consequently predicted adult height (PAH) in boys with high estrogen level.
Thamar Mahmoud
doaj   +1 more source

Home - About - Disclaimer - Privacy